- Home
- FINW vs CDXS Comparison
FINW vs CDXS Comparison
Compare FINW & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FINW | CDXS |
|---|---|---|
| Founded | 1999 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.7M | 256.3M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | FINW | CDXS |
|---|---|---|
| Price | $14.88 | $2.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.6K | ★ 1.4M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.51 | ★ 43.82 |
| EPS | ★ 1.13 | N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | $160.48 | $7.73 |
| Revenue Next Year | $35.27 | $14.24 |
| P/E Ratio | $13.77 | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $13.49 | $0.96 |
| 52 Week High | $22.49 | $3.87 |
Technical Indicators
Market Signals| Indicator | FINW | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 32.40 | 66.96 |
| Support Level | N/A | $2.37 |
| Resistance Level | $18.95 | $2.83 |
| Average True Range (ATR) | 0.53 | 0.18 |
| MACD | -0.14 | -0.00 |
| Stochastic Oscillator | 3.69 | 66.13 |
Price Performance
Historical ComparisonAbout FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and commercial customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.
About CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.